-
VectorY
Created in 2020
-
-
Up & running (A)
Existing signals show a regular activity -
Social networks
10,855 -
Activities
-
Technologies
-
Entity types
-
Location
Science Park 301, 1098 XH Amsterdam, Netherlands
Amsterdam
Netherlands
-
Employees
Scale: 51-200
Estimated: 103
-
Engaged catalyst
9
0 0 -
Added in Motherbase
1 year, 4 months ago
-
Value proposition
VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions.
VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for large disease areas of high unmet medical need.
By combining state-of-the-art technologies and novel and scientific concepts, VectorY’s mission is to bring innovative therapies to patients worldwide.
Founded in August 2020, and based in the Amsterdam Science Park, VectorY is a fully integrated gene therapy company focused on the development of innovative therapeutics such as vectorized antibodies for both CNS and somatic disorders, with a special focus on muscle diseases.
With R&D and manufacturing facilities in Amsterdam, VectorY develops proprietary & partnered programs based on its novel AAV-based vectorized antibody & gene therapy platform. Product candidates are based on new vector technologies, which will enable the next generation of highly scalable manufacturing processes within VectorY’s own manufacturing facilities. Our manufacturing capabilities will include a state-of-the-art multi-product GMP facility in the Netherlands, with the capability to deliver suspension based AAV viral vector manufacturing of up to 2000L for both clinical and commercial supply.
-
VectorY Therapeutics
A biotech company dedicated to developing transformative medicines for people with neurodegenerative diseases using cutting-edge science and technologies.
https://www.vectorytx.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
Shionogi & Co., Ltd
Pharmaceutical, Pharmaceutical Manufacturing (Auto) |
Shionogi & Co., Ltd
Pharmaceutical, Pharmaceutical Manufacturing (Auto) |
Other
30 Apr 2026 |
|
|
Takeda
Pharmaceutical, Pharmaceutical Manufacturing (Auto) |
Takeda
Pharmaceutical, Pharmaceutical Manufacturing (Auto) |
Other
30 Apr 2026 |
|
|
Biogen
Biotechnology, Biotechnology Research (Auto) |
Biogen
Biotechnology, Biotechnology Research (Auto) |
Other
30 Apr 2026 |
|
|
StartupAmsterdam
Startup accelerator & VC, Government Administration (Auto) |
StartupAmsterdam
Startup accelerator & VC, Government Administration (Auto) |
Other
9 May 2026 |
|
|
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing (Auto) |
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing (Auto) |
Other
30 Apr 2026 |
|
|
GSK
Pharmaceutical, Pharmaceutical Manufacturing (Auto) |
GSK
Pharmaceutical, Pharmaceutical Manufacturing (Auto) |
Other
30 Apr 2026 |
|
|
Novartis
Pharmaceutical, Pharmaceutical Manufacturing (Auto) |
Novartis
Pharmaceutical, Pharmaceutical Manufacturing (Auto) |
Other
30 Apr 2026 |
|
|
Hello Tomorrow
Trade show, Business Consulting and Services (Auto) |
Hello Tomorrow
Trade show, Business Consulting and Services (Auto) |
Other
30 Apr 2026 |
|
|
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing (Auto) |
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing (Auto) |
Other
30 Apr 2026 |
|
|